The Conversation (0)
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
- Wolfe Research Healthcare Conference on Tuesday, November 10 at 11:20 AM Eastern Time
- UBS Global Biopharma Conference on Tuesday, November 17 at 10:00 AM Greenwich Mean Time
- Jefferies Global Healthcare Conference on Tuesday, November 17 at 2:30 PM Greenwich Mean Time
- Citi's Global Healthcare Conference on Tuesday, December 1 at 11:00 AM Eastern Time
- Annual Evercore Healthcare Conference on Wednesday, December 2 at 11:40 AM Eastern Time
The live webcasts can be accessed on the company's investor relations website at investors.gilead.com . The replays will be available for at least 30 days following each presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company's website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261030499668/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
